Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols.


Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Jun 2021
Historique:
revised: 11 02 2020
received: 17 12 2020
accepted: 31 03 2021
pubmed: 19 4 2021
medline: 10 7 2021
entrez: 18 4 2021
Statut: ppublish

Résumé

To present the acceptance and the commissioning, to define the reference dose, and to prepare the reference data for a quality assessment (QA) program of an ultra-high dose rate (UHDR) electron device in order to validate it for preclinical animal FLASH radiotherapy (FLASH RT) experiments and for FLASH RT clinical human protocols. The Mobetron The acceptance tests were all within the tolerances of the company's acceptance protocol. The linearity with pulse width was within 1.5% in all cases. The pulse repetition frequency did not affect the delivered dose more than 2% in all cases but 90 Hz, for which the larger difference was 3.8%. The reference dosimetry showed a good agreement within the alanine and films with variations of 2.2% or less. The short-term (resp. long-term) stability was less than 1.0% (resp. 1.8%) and was the same in both CONV and UHDR modes. PDDs, profiles, and reference dosimetry were measured at two positions, providing data for two specific dose rates (about 9 Gy/pulse and 3 Gy/pulse). Maximal beam size was 4 and 6 cm at 90% isodose in the two positions tested. There was no difference between CONV and UHDR mode in the beam characteristics tested. The device is commissioned for FLASH RT preclinical biological experiments as well as FLASH RT clinical human protocols.

Identifiants

pubmed: 33866565
doi: 10.1002/mp.14885
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3134-3142

Informations de copyright

© 2021 American Association of Physicists in Medicine.

Références

Favaudon V, Caplier L, Monceau V, et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 2014;6:245ra93
Vozenin MC, Hendry JH, Limoli CL. Biological benefits of ultra-high dose rate FLASH radiotherapy: sleeping beauty awoken. Clin Oncol (R Coll Radiol). 2019;31:407-415.
Moeckli R, Germond J-F, Bailat C, et al. In Regard to van Marlen et al. Int J Radiat Oncol Biol Phys. 2020;107:1012-1013.
Montay-Gruel P, Acharya MM, Petersson K, et al. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species. Proc Natl Acad Sci. 2019;116:10943-10951. https://doi.org/10.1073/pnas.1901777116:201901777.
Vozenin M-C, De Fornel P, Petersson K, et al. The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clin Cancer Res. 2019;25:35-42.
Montay-Gruel P, Bouchet A, Jaccard M, et al. X-rays can trigger the FLASH effect: ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice. Radiother Oncol. 2018;129:582-588.
Montay-Gruel P, Petersson K, Jaccard M, et al. Irradiation in a flash: unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s. Radiother Oncol. 2017;124:365-369.
Simmons DA, Lartey FM, Schüler E, et al. Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation. Radiother Oncol. 2019;139:4-10.
Bourhis J, Sozzi WJ, Jorge PG, et al. Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol. 2019;139:18-22.
Diffenderfer ES, Verginadis II, Kim MM, et al. Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system. Int J Radiat Oncol Biol Phys. 2020;106:440-48.
Bourhis J, Montay-Gruel P, Gonçalves Jorge P, et al. Clinical translation of FLASH radiotherapy: why and how? Radiother Oncol. 2019;139:11-17.
Harrington KJ. Ultrahigh dose-rate radiotherapy: next steps for FLASH-RT. Clin Cancer Res. 2019;25:3-5.
Jorge PG, Jaccard M, Petersson K, et al. Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate. Radiother Oncol. 2019;139:34-39.
Jaccard M, Durán MT, Petersson K, et al. High dose-per-pulse electron beam dosimetry: commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use. Med Phys. 2018;45:863-874.
Lempart M, Blad B, Adrian G, et al. Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation. Radiother Oncol. 2019;139:40-45.
Lansonneur P, Favaudon V, Heinrich S, Fouillade C, Verrelle P, De Marzi L. Simulation and experimental validation of a prototype electron beam linear accelerator for preclinical studies. Physica Med. 2019;60:50-57.
Schüler E, Trovati S, King G, et al. Experimental platform for ultra-high dose rate FLASH irradiation of small animals using a clinical linear accelerator. Int J Radiat Oncol Biol Phys. 2017;97:195-203.
Jaccard M, Petersson K, Buchillier T, et al. High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films. Med Phys. 2017;44:725-735.
Gondré M, Jorge PG, Vozenin M-C, et al. Optimization of alanine measurements for fast and accurate dosimetry in FLASH radiation therapy. Radiat Res. 2020;194:573-579.
Beddar AS, Biggs PJ, Chang S, et al. Intraoperative radiation therapy using mobile electron linear accelerators: Report of AAPM Radiation Therapy Committee Task Group No. 72. Med Phys. 2006;33:1476-1489.
Wootton LS, Meyer J, Kim E, Phillips M. Commissioning, clinical implementation, and performance of the Mobetron 2000 for intraoperative radiation therapy. J Appl Clin Med Phys. 2017;18:230-242.
Andreo P, Burns DT, Hohlfeld K, et al. IAEA Technical report Series. No. 398:Vienna 2000.
Khan FM, Doppke KP, Hogstrom KR, et al. Clinical electron-beam dosimetry: Report of AAPM Radiation Therapy Committee Task Group No. 25. Med Phys. 1991;18:73-109.
Winkler P, Odreitz-Stark S, Haas E, Thalhammer M, Partl R. Commissioning, dosimetric characterization and machine performance assessment of the LIAC HWL mobile accelerator for Intraoperative Radiotherapy. Zeitschrift für Medizinische Physik. 2020;30:279-288.
Felici G, Barca P, Barone S, et al. Transforming an IORT linac into a FLASH research machine: procedure and dosimetric characterization. Frontiers Phys. 2020;8:374.
Petersson K, Jaccard M, Germond J-F, et al. High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber. Med Phys. 2017;44:1157-1167.

Auteurs

Raphaël Moeckli (R)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Patrik Gonçalves Jorge (P)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Veljko Grilj (V)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Roxane Oesterle (R)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Nicolas Cherbuin (N)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Jean Bourhis (J)

Radio-Oncology Department, Lausanne University Hospital and Lausanne University, Rue du Bugnon 46, Lausanne, CH-1011, Switzerland.

Marie-Catherine Vozenin (MC)

Radio-Oncology Department, Lausanne University Hospital and Lausanne University, Rue du Bugnon 46, Lausanne, CH-1011, Switzerland.

Jean-François Germond (JF)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

François Bochud (F)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Claude Bailat (C)

Institute of Radiation Physics, Lausanne University Hospital and Lausanne University, Rue du Grand-Pré 1, Lausanne, CH-1007, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH